Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health

• Mireille M. Hermans, MSc,
• Suzanne G.M.A. Pasmans, MD, PhD,
• Peter C.J. de Laat, MD, PhD,
• Martijn G. Slieker, MD, PhD,
• Elodie J. Mendels, MD,
• Marlies de Graaf, MD, PhD,
• Hester R. Langeveld, MD, PhD,
• Renske Schappin, PhD,
• André B. Rietman, PhD,
• Corstiaan C. Breugem, MD, PhD,
• Johannes M.P.J. Breur, MD, PhD,
• Saskia N. de Wildt, MD, PhD,
• Martine F. Raphael, MD, PhD

Affiliations

Mireille M. Hermans, MSc

Department of Dermatology–Center of Pediatric Dermatology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, the Netherlands

Suzanne G.M.A. Pasmans, MD, PhD

Department of Dermatology–Center of Pediatric Dermatology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, the Netherlands; Correspondence to: Suzanne G. M. A. Pasmans, MD, PhD, Department of Dermatology–Center of Pediatric Dermatology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam; Vascular Anomaly Center Rotterdam, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands

Peter C.J. de Laat, MD, PhD

Department of Pediatrics (Hemato-oncology), Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, the Netherlands

Martijn G. Slieker, MD, PhD

Department of Pediatric Cardiology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, the Netherlands

Elodie J. Mendels, MD

Department of Dermatology–Center of Pediatric Dermatology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, the Netherlands

Marlies de Graaf, MD, PhD

Department of Dermatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, the Netherlands

Hester R. Langeveld, MD, PhD

Department of Intensive Care and Pediatric Surgery, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, the Netherlands

Renske Schappin, PhD

Department of Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht, the Netherlands; Department of Dermatology–Center of Pediatric Dermatology, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, Center of Rare Skin Diseases, Vascular Anomaly Center Erasmus MC Rotterdam, the Netherlands

André B. Rietman, PhD

Department of Child and Adolescent Psychology/Psychiatry, Erasmus MC Sophia Children’s Hospital, University Medical Center Rotterdam, the Netherlands

Corstiaan C. Breugem, MD, PhD

Department of Plastic Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, the Netherlands; Department of Plastic, Reconstructive and Hand Surgery, Amsterdam UMC Location University of Amsterdam, the Netherlands

Johannes M.P.J. Breur, MD, PhD

Department of Pediatric Cardiology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, the Netherlands

Saskia N. de Wildt, MD, PhD

Department of Pharmacology and Toxicology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands

Martine F. Raphael, MD, PhD

Department of Dermatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, UMC Utrecht Center for Vascular Anomalies, the Netherlands; Department Emma Children’s Hospital, Amsterdam UMC Location University of Amsterdam, the Netherlands